Report : Asia Pacific Hypodermic Needles Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Safety Needles, and Non-safety Needles), Application (Drug Delivery, Vaccination, and Blood Specimen Collection), End-Users (Diagnostic Centers, Hospitals and Clinics, and Home Health Care), and Usage (Disposable, and Reusable)

Safety Needles Segment has the Largest Share of Type in the Asia Pacific Hypodermic Needles Market during 2021–2028

According to our latest study on “Asia Pacific Hypodermic Needles Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type, Application, End User, and Usage,” the market is projected to reach US$ 1,092.6 million by 2028 from US$ 668.7 million in 2021; it is expected to grow at a CAGR of 7.3% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of chronic diseases, and surge in demand for vaccines. However, availability of alternatives is hampering the growth of the market to a certain extent.

The demand for hypodermic needles is growing continuously as the demand for the vaccine is increasing for COVID-19. Thus, the market players are actively involved in the market development activities in the COVID-19 pandemic. For instance, In April 2021, Misawa Medical Industry Co., Ltd. has developed "Low Dead Space Needles," which can reduce the quantity of medicinal liquid left in the syringe and will begin selling them in Japan on April 1, 2021. This eliminates the need for a particular syringe and reduces the "dead space" in which the liquid lingers in the syringe. Furthermore, one vial of the new COVID vaccines developed by Pfizer Inc can offer six injections. In June 2020, Misawa Medical Industry Co., Ltd. extended its needle manufacturing facilities, boosting its annual production capacity from 1.9 billion to 3 billion pieces. The company is currently strengthening the vaccine needle production system while employing other product production lines, and the company will continue to make efforts to make vaccination easier.

Based on type, the Asia Pacific hypodermic needles market is bifurcated into safety needles and non-safety needles. In 2021, the safety needles segment is estimated to account for the largest market share of the type segment in the Asia Pacific hypodermic needles market. The growth of these segments is attributed to increasing prevalence of chronic disease, increasing needle stick injuries, and increasing regulation to reduce disease transmission through syringes.

Terumo Corporation, BD, B. Braun Melsungen AG, Catalent Inc., Cardinal Health Inc., Nipro Corp., Vygon, and Barber of Sheffield are among the leading companies in the Asia Pacific hypodermic needles market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for hypodermic needles market is segmented into type, application, end user, and usage. Based on type, the Asia Pacific hypodermic needles market is segmented into safety needles, and non-safety needles. Based on application, the hypodermic needles market is segmented into drug delivery, vaccination, and blood specimen collection. Based on end user, the hypodermic needles market is segmented into diagnostic centers, hospitals and clinics, and home health care. Based on usage, the hypodermic needles market is segmented into disposable, and reusable. Geographically, the hypodermic needles market is segmented into Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific).

The report segments Asia Pacific hypodermic needles market as follows:

The Asia Pacific hypodermic needles market is segmented on the basis on ingredient type and sources. Based on ingredient type, the Asia Pacific hypodermic needles market is segmented into Probiotics and prebiotics, omega-3 fatty acids, vitamins, carotenoids and antioxidants, plant extracts, minerals, amino acids, proteins and peptides, and others. Based on sources, the market is segmented into plant animal, and microbial.

By Country                                                    

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Asia Pacific

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com

Download Free PDF Brochure